Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998884029> ?p ?o ?g. }
- W1998884029 endingPage "22" @default.
- W1998884029 startingPage "16" @default.
- W1998884029 abstract "Objectives:The efficacy and safety of plerixafor, an antagonist of the CXCR4 receptor, in combination with G-CSF has been demonstrated in patients suffering from Iymphoma and multiple myeloma (MM) eligible for autologous haematopoietic stem cell collection. However, different reimbursement criteria have been applied in different countries to select patients eligible for treatment with plerixafor. The objective of this observational study was to describe the plerixafor prescription modalities in daily practice in Belgium.Methods:This open-label, prospective, observational study was conducted in 11 Belgian centres in 114 patients with lymphoma (Hodgkin’s and non-Hodgkin’s lymphoma) or MM who were treated with plerixafor according to the SmPC between April 2011 and October 2012. Patients included in another clinical trial with plerixafor were excluded from the study.Results:The use of plerixafor in patients with MM or lymphoma was effective, with a success rate (defined as a total yield >2×106 CD34+ cells/kg) of 77%, and well tolerated (one SAE reported). Optimal collection (defined as a total yield >4×106 CD34+ cells/kg) was obtained for 43% of the study population (31% in lymphoma patients, compared to 61% in patients with MM). The use of plerixafor was in line with the SmPC and the Belgian reimbursement criteria for all patients.Conclusion:This study is showing that the use of plerixafor according to Belgian reimbursement criteria results in similar efficacy and safety as in other centres and countries worldwide." @default.
- W1998884029 created "2016-06-24" @default.
- W1998884029 creator A5014555073 @default.
- W1998884029 creator A5018467091 @default.
- W1998884029 creator A5020059834 @default.
- W1998884029 creator A5033063736 @default.
- W1998884029 creator A5036582191 @default.
- W1998884029 creator A5037134717 @default.
- W1998884029 creator A5051513022 @default.
- W1998884029 creator A5054068538 @default.
- W1998884029 creator A5057205004 @default.
- W1998884029 creator A5077504536 @default.
- W1998884029 date "2014-09-18" @default.
- W1998884029 modified "2023-09-26" @default.
- W1998884029 title "Plerixafor prescription modalities in autologous haematopoietic stem cell mobilization in Belgium" @default.
- W1998884029 cites W1543191049 @default.
- W1998884029 cites W1591193872 @default.
- W1998884029 cites W1944227066 @default.
- W1998884029 cites W1989539145 @default.
- W1998884029 cites W1991500911 @default.
- W1998884029 cites W1994909730 @default.
- W1998884029 cites W1995712528 @default.
- W1998884029 cites W2000125803 @default.
- W1998884029 cites W2008510614 @default.
- W1998884029 cites W2009197622 @default.
- W1998884029 cites W2009299193 @default.
- W1998884029 cites W2009443185 @default.
- W1998884029 cites W2017458921 @default.
- W1998884029 cites W2019381460 @default.
- W1998884029 cites W2020445243 @default.
- W1998884029 cites W2020806642 @default.
- W1998884029 cites W2022271217 @default.
- W1998884029 cites W2025709882 @default.
- W1998884029 cites W2037659374 @default.
- W1998884029 cites W2078466049 @default.
- W1998884029 cites W2080350836 @default.
- W1998884029 cites W2085269642 @default.
- W1998884029 cites W2103201676 @default.
- W1998884029 cites W2121413131 @default.
- W1998884029 cites W2145085377 @default.
- W1998884029 cites W2170762893 @default.
- W1998884029 cites W2325869355 @default.
- W1998884029 cites W2335097692 @default.
- W1998884029 doi "https://doi.org/10.1179/2295333714y.0000000077" @default.
- W1998884029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25236359" @default.
- W1998884029 hasPublicationYear "2014" @default.
- W1998884029 type Work @default.
- W1998884029 sameAs 1998884029 @default.
- W1998884029 citedByCount "1" @default.
- W1998884029 countsByYear W19988840292016 @default.
- W1998884029 crossrefType "journal-article" @default.
- W1998884029 hasAuthorship W1998884029A5014555073 @default.
- W1998884029 hasAuthorship W1998884029A5018467091 @default.
- W1998884029 hasAuthorship W1998884029A5020059834 @default.
- W1998884029 hasAuthorship W1998884029A5033063736 @default.
- W1998884029 hasAuthorship W1998884029A5036582191 @default.
- W1998884029 hasAuthorship W1998884029A5037134717 @default.
- W1998884029 hasAuthorship W1998884029A5051513022 @default.
- W1998884029 hasAuthorship W1998884029A5054068538 @default.
- W1998884029 hasAuthorship W1998884029A5057205004 @default.
- W1998884029 hasAuthorship W1998884029A5077504536 @default.
- W1998884029 hasBestOaLocation W19988840292 @default.
- W1998884029 hasConcept C126322002 @default.
- W1998884029 hasConcept C129470790 @default.
- W1998884029 hasConcept C13373296 @default.
- W1998884029 hasConcept C141071460 @default.
- W1998884029 hasConcept C143998085 @default.
- W1998884029 hasConcept C170493617 @default.
- W1998884029 hasConcept C2778828106 @default.
- W1998884029 hasConcept C2779338263 @default.
- W1998884029 hasConcept C2780492938 @default.
- W1998884029 hasConcept C71924100 @default.
- W1998884029 hasConceptScore W1998884029C126322002 @default.
- W1998884029 hasConceptScore W1998884029C129470790 @default.
- W1998884029 hasConceptScore W1998884029C13373296 @default.
- W1998884029 hasConceptScore W1998884029C141071460 @default.
- W1998884029 hasConceptScore W1998884029C143998085 @default.
- W1998884029 hasConceptScore W1998884029C170493617 @default.
- W1998884029 hasConceptScore W1998884029C2778828106 @default.
- W1998884029 hasConceptScore W1998884029C2779338263 @default.
- W1998884029 hasConceptScore W1998884029C2780492938 @default.
- W1998884029 hasConceptScore W1998884029C71924100 @default.
- W1998884029 hasIssue "1" @default.
- W1998884029 hasLocation W19988840291 @default.
- W1998884029 hasLocation W19988840292 @default.
- W1998884029 hasLocation W19988840293 @default.
- W1998884029 hasLocation W19988840294 @default.
- W1998884029 hasOpenAccess W1998884029 @default.
- W1998884029 hasPrimaryLocation W19988840291 @default.
- W1998884029 hasRelatedWork W1863164085 @default.
- W1998884029 hasRelatedWork W1969078983 @default.
- W1998884029 hasRelatedWork W2007950619 @default.
- W1998884029 hasRelatedWork W2010593183 @default.
- W1998884029 hasRelatedWork W2040205738 @default.
- W1998884029 hasRelatedWork W2096150843 @default.
- W1998884029 hasRelatedWork W2128874744 @default.
- W1998884029 hasRelatedWork W2166322995 @default.
- W1998884029 hasRelatedWork W2357401886 @default.